中国药物经济学
中國藥物經濟學
중국약물경제학
CHINA JOURNAL OF PHARMACEUTICAL ECONOMICS
2014年
3期
280-281
,共2页
脑血栓形成%尿激酶%溶栓
腦血栓形成%尿激酶%溶栓
뇌혈전형성%뇨격매%용전
Cerebral thrombosis%Urokinase%Thrombolysis
目的：观察尿激酶溶栓对脑血栓形成的疗效。方法入选患者使用NS100ml+UK150万静脉滴注。结果16例溶栓患者中溶栓后24h神经功能缺损评分对比，基本治愈7例，显效6例，有效2例，无效1例。结论脑血栓形成早期尿激酶溶栓在基层医院有其可行性。
目的：觀察尿激酶溶栓對腦血栓形成的療效。方法入選患者使用NS100ml+UK150萬靜脈滴註。結果16例溶栓患者中溶栓後24h神經功能缺損評分對比，基本治愈7例，顯效6例，有效2例，無效1例。結論腦血栓形成早期尿激酶溶栓在基層醫院有其可行性。
목적：관찰뇨격매용전대뇌혈전형성적료효。방법입선환자사용NS100ml+UK150만정맥적주。결과16례용전환자중용전후24h신경공능결손평분대비，기본치유7례，현효6례，유효2례，무효1례。결론뇌혈전형성조기뇨격매용전재기층의원유기가행성。
Objective To observe the curative effect of urokinase thrombolysis in cerebral thrombosis.Methods To selected patients with NS100ml+UK150 intravenous drip.Results 16 cases of thrombolysis in patients with 24 hours after thrombolysis neural function defect scale contrast.Basic cured 7 cases,6 cases were markedly effective, effective in 2 cases,1 had no effect.Conclusion The cerebral thrombosis early urokinase thrombolysis has its feasibility in basic-level hospitals.
